NYSE:ALB - Albemarle Stock Price, News, Headlines & Rumors

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle announced a quarterly dividend on Thursday, July 26th. Stockholders of record on Friday, September 14th will be paid a dividend of $0.335 per share on Monday, October 1st. This represents a $1.34 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date is Thursday, September 13th. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) released its quarterly earnings results on Tuesday, August, 7th. The specialty chemicals company reported $1.36 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.28 by $0.08. The specialty chemicals company had revenue of $853.87 million for the quarter, compared to analysts' expectations of $799.49 million. Albemarle had a net margin of 10.17% and a return on equity of 14.51%. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, November, 14th 2018. View Earnings Estimates for Albemarle.

Albemarle updated its FY18 earnings guidance on Tuesday, August, 7th. The company provided earnings per share guidance of $5.30-5.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.26. The company issued revenue guidance of $3.3-3.5 vln, compared to the consensus revenue estimate of $3.32 billion.

22 equities research analysts have issued 1 year price objectives for Albemarle's shares. Their forecasts range from $106.00 to $157.00. On average, they anticipate Albemarle's share price to reach $133.2374 in the next twelve months. This suggests a possible upside of 36.9% from the stock's current price. View Analyst Price Targets for Albemarle.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 hold ratings and 20 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Albemarle.

Some companies that are related to Albemarle include Eastman Chemical (EMN), Sinopec Shanghai Petrochemical (SHI), Hexcel (HXL), PolyOne (POL), Trinseo (TSE), Rogers (ROG), Kraton (KRA), A Schulman (SHLM), AdvanSix (ASIX), Cereplast (CERPQ) and ForceField Energy (FNRG).

Media headlines about ALB stock have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Albemarle earned a media and rumor sentiment score of 0.13 on Accern's scale. They also assigned media coverage about the specialty chemicals company an impact score of 46.59 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future. View Recent Headlines for Albemarle.

Albemarle's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.50%), Jennison Associates LLC (6.62%), Bank of New York Mellon Corp (4.88%), Baillie Gifford & Co. (2.36%), Iridian Asset Management LLC CT (1.83%) and Bank of America Corp DE (1.30%). Company insiders that own Albemarle stock include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Baird Financial Group Inc., FMR LLC, Dividend Assets Capital LLC, Bank of New York Mellon Corp, Artisan Partners Limited Partnership, BlackRock Inc. and Los Angeles Capital Management & Equity Research Inc.. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Matthew Juneau. View Insider Buying and Selling for Albemarle.

ALB stock was bought by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Jennison Associates LLC, Rovida Advisors Inc., Sei Investments Co., Joho Capital LLC, Federated Investors Inc. PA, Handelsbanken Fonder AB and US Bancorp DE. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $97.33.

Albemarle has a market capitalization of $10.68 billion and generates $3.07 billion in revenue each year. The specialty chemicals company earns $54.85 million in net income (profit) each year or $4.59 on an earnings per share basis. Albemarle employs 5,400 workers across the globe.

Albemarle's mailing address is 4350 CONGRESS STREET SUITE 700, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700.